JADCO 2017 JADCO vs Dwayne Walker

In October 2017 the Jamaica Anti-Doping Commission (JADCO) reported an anti-doping rule violation against the bodybuilder Dwayne Walker after his sample tested positive for the prohibited susbstance Ibutamoren. After notification the Athlete in his submission accepted the test results and a provisional suspension. Hereafter he failed to respond to the JADCO communications.

The Jamaica Anti-Doping Disciplinary Panel finds that the test result establish the presence of a prohibited substance and accordingly that the Athlete committed an anti-doping rule violation. The Panel holds that the Athlete already had accepted the test result and he made no request for a hearing.

Therefore the Jamaica Anti-Doping Disciplinary Panel decides on 11 October 2018 to impose a 4 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 11 October 2017.

Original document

Parameters

Legal Source
National Decisions
Date
11 October 2018
Arbitrator
Gammon, Kent P.
Palmer, Dixeth
Vassell, Marjorie
Original Source
Jamaica Anti-Doping Commission (JADCO)
Country
Jamaica
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Waiver of "right to be heard"
Sport/IFs
Bodybuilding & Fitness (IFBB) - International Federation of Bodybuilding & Fitness
Other organisations
Jamaica Anti-Doping Commission (JADCO)
Laboratories
Montreal, Canada: Laboratoire de controle du dopage INRS-Institut Armand-Frappier
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Ibutamoren
Document type
Pdf file
Date generated
11 July 2019
Date of last modification
6 August 2019
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin